Zhang Yaodan, Chen Fang, Ren Fengchun
Department of Neurology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
Geriatrics Department, Sichuan Provincial People's Hospital Jinniu Hospital (Chengdu Jinniu District People's Hospital), Chengdu, Sichuan, China.
Mol Cell Biochem. 2025 Sep 18. doi: 10.1007/s11010-025-05392-y.
Mild cognitive impairment (MCI) is a common non-motor manifestation of Parkinson's disease (PD) and often precedes dementia. However, evidence on its demographic and clinical risk factors remains inconsistent. This study aimed to synthesize available data through a meta-analysis to identify determinants of MCI in PD.
This systematic review and meta-analysis followed PRISMA guidelines. Electronic databases were searched using MeSH terms and validated keywords. Studies were selected through a multi-step screening process by independent reviewers. Data extraction and quality assessment were performed using the Newcastle-Ottawa Scale. Meta-analyses were conducted using Comprehensive Meta-Analysis (v2). Random- or fixed-effects models were applied based on heterogeneity (I threshold = 50%). Beggs and Mazumdar test assessed publication bias, with significance set at (P < 0.1).
This meta-analysis included 33 studies, Significant risk factors for MCI in individuals with PD included older age (effect size = 0.4, 95% CI: 0.315-0.498, P ≤ 0.001), older age at disease onset (effect size = 0.18, 95% CI: 0.05-0.327, P ≤ 0.001), and longer disease duration (effect size = 0.14, 95% CI: 0.08-0.2, P ≤ 0.001). Higher educational attainment showed a protective effect (effect size = -0.438, 95% CI: -0.555 to -0.321, P ≤ 0.001). No significant association was found between gender and MCI (OR = 0.899, 95% CI: 0.749-1.079, P = 0.253). Disease severity, based on UPDRS and Hoehn and Yahr scales, was significantly associated with increased MCI risk.
Advanced age, later disease onset, longer disease duration, and greater severity are key risk factors for MCI in PD. These findings highlight the need for early detection and proactive management to guide clinical decisions.
轻度认知障碍(MCI)是帕金森病(PD)常见的非运动表现,且常先于痴呆出现。然而,关于其人口统计学和临床风险因素的证据仍不一致。本研究旨在通过荟萃分析整合现有数据,以确定帕金森病中轻度认知障碍的决定因素。
本系统评价和荟萃分析遵循PRISMA指南。使用医学主题词(MeSH)和经过验证的关键词检索电子数据库。研究由独立评审员通过多步骤筛选过程进行选择。使用纽卡斯尔-渥太华量表进行数据提取和质量评估。使用综合荟萃分析(v2)进行荟萃分析。根据异质性(I阈值=50%)应用随机或固定效应模型。Beggs和Mazumdar检验评估发表偏倚,显著性设定为(P<0.1)。
本荟萃分析纳入了33项研究。帕金森病患者发生轻度认知障碍的显著风险因素包括年龄较大(效应量=0.4,95%可信区间:0.315-0.498,P≤0.001)、发病时年龄较大(效应量=0.18,95%可信区间:0.05-0.327,P≤0.001)和病程较长(效应量=0.14,95%可信区间:0.08-0.2,P≤0.001)。较高的教育程度显示出保护作用(效应量=-0.438,95%可信区间:-0.555至-0.321,P≤0.001)。未发现性别与轻度认知障碍之间存在显著关联(比值比=0.899,95%可信区间:0.749-1.079,P=0.253)。基于统一帕金森病评定量表(UPDRS)和霍恩及雅尔分级量表的疾病严重程度与轻度认知障碍风险增加显著相关。
高龄、发病较晚、病程较长和病情较重是帕金森病中轻度认知障碍的关键风险因素。这些发现凸显了早期检测和积极管理以指导临床决策的必要性。